| Serial Number | 98525292 |
| Word Mark | SMB |
| Filing Date | Monday, April 29, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, July 28, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 17, 2024 |
| Goods and Services | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; vitamins and mineral supplements; crude medicines for the treatment of gastrointestinal diseases; crude medicines, namely, medicinal preparations for use in dermatology; crude medicines, namely, plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; crude medicines, namely, medicines for treating neurological disease, muscular disease, ischemic disease, renal disease, and cancer; antibacterial pharmaceuticals; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for the treatment of infectious diseases; diagnostic radiopharmaceutical preparations; pharmaceutical drugs for the treatment of metabolic disorders, namely, obesity, comorbidities secondary to obesity, metabolic syndrome, and related metabolic diseases; pharmaceutical drugs for the treatment of joint disorders and osteoarthritis; cough pastilles for pharmaceutical purposes; lotions for pharmaceutical purposes, namely, medicated skin lotions, medicated hair lotions, medicated sunburn lotions, calamine lotion, medicated after-shave lotions, collyrium, anti-bacterial hand lotions; chemical preparations for pharmaceutical use, namely, for the treatment of neurodegenerative disorders, neurological conditions, cancer, skin conditions, or for use in wound healing or photodynamic therapy; chemical preparations for pharmaceutical use, namely, for the treatment of fungal, viral, bacterial and infectious diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CEN CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Miryang-si 50404 KR |
| Party Name | CEN CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Miryang-si 50404 KR |
| Event Date | Event Description |
| Monday, April 29, 2024 | NEW APPLICATION ENTERED |
| Monday, April 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 20, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 20, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 20, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 14, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, November 20, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 11, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, July 28, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 28, 2025 | SOU EXTENSION 1 FILED |
| Monday, July 28, 2025 | SOU EXTENSION 1 GRANTED |
| Monday, July 28, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |